biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > did JD leave too?

<< Previous

Bullboard Posts

Next >>

Comment by prophetoffactzon Sep 23, 2022 1:25pm

134 Views

Post# 34982435

RE:RE:did JD leave too?

Goldman Sachs cuts S&P 500 2022 year-end target to 3600 from 4300.

The S&P is now at 3681 so if you believe Goldman Sachs has any credibility in this risky environment the sell-off may be nearing exhaustion. 81 more points lower to its year end target.

<< Previous

Bullboard Posts

Next >>

The top 10 Canadian medical stocks